JP Morgan Maintains Overweight on Sempra, Raises Price Target to $106

JP Morgan analyst Christopher Turnure has maintained an Overweight rating on Sempra (NYSE: SRE) and raised the price target from $98 to $106. This adjustment reflects a positive outlook on the company's performance.